EUVIMEDOpdag EUVIMED
Open access · CC BY 4.0

Multi-stage transcriptome analysis identifies hub genes and regulatory mechanisms driving cervical cancer progression

Peng Li, Yawen Shao, Junling Wang, Ru Lin

PeerJ · 2026-05-20 · 14 · e21255

DOI: 10.7717/peerj.21255 ↗

At a glance

Journal article in PeerJ, published online on 2026-05-20. Written by Peng Li and 3 co-authors. Institution: School of Public Health, Lanzhou University, Lanzhou, Gansu, China. Major MEDLINE topics: Uterine Cervical Neoplasms, Gene Expression Profiling, Gene Expression Regulation, Neoplastic, Carcinoma, Squamous Cell. Cited 1 times so far (Crossref); 59 references. The full text is freely available (open access, CC BY 4.0). Funded by: The Lanzhou Science and Technology Plan Project.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background

Cervical cancer (CC) ranks as the fourth most prevalent cancer in women worldwide. While biomarkers exist, previous studies are often limited by public dataset heterogeneity, incomplete spectrum coverage, or lack of clinical validation. To address these limitations, this study aims to profile fresh tissues spanning the full continuum to systematically identify hub genes with dysregulated expression during malignant progression.

Methods

This study collected cervical epithelial tissue from 10 patients each with low-grade squamous intraepithelial lesions (LSIL), high-grade squamous intraepithelial lesions (HSIL), and squamous cell carcinoma (SCC) for transcriptome sequencing. The differentially expressed genes (DEGs) analysis and Mfuzz clustering were employed to identify candidate genes showing monotonic expression trends. Candidate genes were prioritized using a protein–protein interaction (PPI) network with three centrality algorithms and validated in Gene Expression Omnibus to define hub genes. Subsequently, Gene Set Enrichment Analysis (GSEA), immune infiltration analysis, and regulatory network analyses were performed. Finally, hub gene expression was validated via reverse transcription quantitative polymerase chain reaction (RT-qPCR) in an independent clinical cohort.

Results

A total of 1,654 DEGs (HSIL vs. LSIL) and 6,635 DEGs (SCC vs. HSIL) were identified. Mfuzz clustering and PPI analysis yielded nine candidates, with BUB1B, KIF14, and MELK finalized as hub genes via GEO validation. GSEA showed the three hub genes were significantly enriched in multiple shared pathways and exhibited stage-specific differences. Immune infiltration analysis showed no significant association between hub-gene expression and immune cell fractions. Regulatory network prediction implicated miRNAs ( e.g. , hsa-miR-192-5p, hsa-miR-215-5p, hsa-miR-193b-3p) and TFs ( e.g. , AF4, E2F1, FOXA1, KDM5B) as potential upstream regulators. The lncRNAs ( e.g. , KCNQ1OT1, LINC01089, XIST3) were linked to these miRNAs. Finally, RT-qPCR in independent clinical samples confirmed hub-gene expression changes consistent with the bioinformatics findings.

Conclusion

This study found the progressive upregulation of BUB1B, KIF14, and MELK across the LSIL-HSIL-SCC continuum, strengthening existing evidence of their association with cervical oncogenesis and highlighting their potential as candidate biomarkers for CC progression. However, the single-center design, limited sample size, and exploratory nature of the immune infiltration, regulatory network, and drug prediction analyses warrant cautious interpretation and underscore the need for further experimental validation.

Subjects

MeSH terms (MEDLINE)

Uterine Cervical NeoplasmsGene Expression ProfilingGene Expression Regulation, NeoplasticCarcinoma, Squamous CellHumansFemaleDisease ProgressionProtein Interaction MapsGene Regulatory NetworksBiomarkers, TumorTranscriptomeProtein Serine-Threonine Kinases

Author keywords

Bioinformatic analysisBiomarkersCervical cancerRNA sequencing

Substances

Biomarkers, TumorProtein Serine-Threonine Kinases

Authors and institutions

  • School of Public Health, Lanzhou University, Lanzhou, Gansu, China.
  • Cervical Cancer Prevention and Treatment Center, Gansu Provincial Maternity and Child-care Hospital, Lanzhou, Gansu, China.

Funding

  • The Lanzhou Science and Technology Plan Project

Cite

APA

Li, P., Shao, Y., Wang, J., & Lin, R. (2026). Multi-stage transcriptome analysis identifies hub genes and regulatory mechanisms driving cervical cancer progression. PeerJ, 14, e21255. https://doi.org/10.7717/peerj.21255

Vancouver

Li P, Shao Y, Wang J, Lin R. Multi-stage transcriptome analysis identifies hub genes and regulatory mechanisms driving cervical cancer progression. PeerJ. 2026;14:e21255. doi:10.7717/peerj.21255

BibTeX
@article{Li2026,
  author = {Li, Peng and Shao, Yawen and Wang, Junling and Lin, Ru},
  title = {Multi-stage transcriptome analysis identifies hub genes and regulatory mechanisms driving cervical cancer progression},
  journal = {PeerJ},
  year = {2026},
  volume = {14},
  pages = {e21255},
  doi = {10.7717/peerj.21255}
}
Start for free →